InhibrxÂ Inc (INBX) Financials

$110.46

$-0.96 (-0.86%)

As on 11-Sep-2026 12:34EDT

Market cap

$1,783 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

212.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	1.30	0.20	1.80	2.19	7.23
Cost of Revenue	1.68	2.48	2.29	1.19	110.19	2.69
Gross Profit	-1.68	-1.18	-2.09	0.61	-107.99	7.23
Operating Expenses	126.13	133.84	329.36	219.83	21.12	83.80
Operating Profit (EBIT)	-127.81	-135.03	-331.45	-219.22	-129.12	-76.56
Other Income	--	--	--	--	--	--
Profit before Tax	-138.18	-140.05	1,687.57	-239.72	-145.22	-81.77
Provision for Tax	0.00	0.00	0.00	0.00	0.00	0.00
Profit after Tax (Net Income)	-138.18	-140.06	1,687.57	-241.36	-145.23	-81.77
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-52.98	7.99	133.58	43.50	58.06	52.38
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	179.14	104.69	6.45	208.08	205.24	75.61
Current Liabilities	28.06	33.80	40.73	56.31	27.58	22.45
Total Liabilities	182.29	146.48	180.77	307.89	290.88	150.45

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	12.01	13.65	20.37	12.54	10.38	11.34
Current Assets	142.21	132.83	160.40	295.36	280.49	139.11
Total Assets	182.29	146.48	180.77	307.89	290.88	150.45
Total Debt*	5.34	107.01	8.05	210.14	207.10	72.14
Net Current Assets	114.15	99.03	119.67	239.05	-14.51	--

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-129.79	-194.41	-193.31	-115.30	-80.32
Cash Flow from Investing Activities	--	-0.03	-2.60	-4.59	-0.69	-0.81
Cash from Financing Activities	--	101.45	71.68	201.96	258.55	83.77
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-8.88	-9.04	116.58	-4.47	-3.36	-2.12
Cash EPS ($)	--	-8.88	116.74	-4.44	-3.33	-2.12
Adjusted Book Value ($)	--	0.52	9.23	0.81	1.34	1.36
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-8.38	-13.43	-3.58	-2.66	-2.08
Free Cash Flow per Share ($)	--	-8.38	-13.61	-3.66	-2.68	-2.10

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-109.15	853.87	-93.05	-74.53	-68.87
ROE (%)	--	-197.85	1,905.92	-475.31	-263.00	-127.91
ROA (%)	-63.77	-85.60	690.69	-80.62	-65.81	-55.59
EBIT Margin (%)	--	-9,835.15	850,532.50	-11,549.11	-5,795.71	-1,058.83
Net Margin (%)	--	-10,773.46	843,786.00	-13,408.94	-6,625.27	-1,130.80
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	5.50	-0.89	-0.18	-0.70	-0.44
EBIT Growth (%)	22.30	-107.52	918.28	-63.63	-65.93	-18.12
Net Profit Growth (%)	15.59	-108.30	799.19	-66.20	-77.61	-8.11
EPS Growth (%)	17.71	-1.08	27.10	-0.33	-0.58	-0.06
Book Value Growth (%)	-176.28	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-8.74	0.13	-8.51	-7.34	-20.61
Price / Book Value	212.28	153.07	1.67	47.20	18.36	32.16
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.13	-9.62	0.05	-9.61	-7.94	-21.24
Close Price ($)	94.75	79.00	15.40	38.00	24.64	43.67
High Price ($)	155.29	94.57	39.79	39.50	44.99	47.90
Low Price ($)	13.97	10.81	10.80	14.31	7.67	14.27
Market Cap ($ Cr)	1,783.34	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	-3.33	13.39	0.06	4.83	3.57	1.38
Short term debt to equity ratio	-0.05	0.29	0.01	0.05	0.03	0.03
Current Ratio	5.07	3.93	3.94	5.25	10.17	6.20
Quick Ratio	5.07	--	--	--	10.18	6.23
Interest Coverage	-7.88	-10.48	126.09	-6.53	-7.89	-14.68

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	13.62	210.00	43.22	11.72	12.14
Asset Turnover	--	0.01	0.00	0.01	0.01	0.05
Receivable days	--	83.87	1,093.92	105.01	94.56	37.71
Inventory Days	--	--	--	-78.82	-1.88	-8,842.98
Payable days	--	1,117.15	1,614.37	2,956.35	28.92	1,534.31
Cash Conversion Cycle	--	--	--	-2,930.15	63.76	-10,339.58

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.